-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $486

Benzinga·03/23/2026 13:22:29
Listen to the news
Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price target from $466 to $486.